- Home
- Slides
- Home
- Tools and Resources
- Research Summaries for Consumers, Clinicians, and Policymakers
- Search for Research Summaries, Reviews, and Reports
- Research Available for Comment
- Submit a Suggestion for Research
- Submit Scientific Information Packets
- Comparative Effectiveness Research Grant and ARRA Awards
- News and Announcements
- What Is Comparative Effectiveness Research
- Who Is Involved in the Effective Health Care Program
- What Is the Effective Health Care Program
Slides
Slides: 1–12 of 43
Effectiveness of Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis
Outline of Material
Health Impact of Cystic Fibrosis in the United States
Characteristics of CF: Origin of the Disease
Clinical Features of Cystic Fibrosis
Presentation: Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis
Keywords: pulmonary | disease | pancreatic | insufficiency | nutritional | deficiency | malnutrition | CF-related diabetes | diabetes | cystic fibrosis | CF | rhGH | recombinant human growth hormone | human growth hormone | HGH
Rationale for Use of Recombinant Human Growth Hormone (rhGH) in Patients With CF
Presentation: Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis
Keywords: nutrition | nutritional | deficiencies | deficiency | malnutrition | anabolic | cystic fibrosis | CF | rhGH | recombinant human growth hormone | human growth hormone | HGH
Approved Therapeutic Uses of rhGH
Agency for Healthcare Research and Quality (AHRQ) Comparative Effectiveness Review (CER) Development
Clinical Questions Addressed by the CER (1)
Presentation: Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis
Keywords: intermediate outcomes | health outcomes | pulmonary function | body composition | bone mineralization | pulmonary exacerbation | mortality risk | health related quality of life | HRQoL | QoL | quality of life | cystic fibrosis | CF | rhGH | recombinant human growth hormone | human growth hormone | HGH
Clinical Questions Addressed by the CER (2)
Rating the Strength of Evidence From the CER: A Modification of the GRADE Methodology
Outcomes of Interest in Studies of rhGH Treatment of Patients With CF
Presentation: Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis
Keywords: intermediate outcomes | health outcomes | outcomes | pulmonary function | anthropometrics | bone mineralization | exercise tolerance | hospitalization rate | intravenous antibiotics | antibiotic use | health related quality of life | HRQoL | QoL | quality of life | bone consequences | mortality | cystic fibrosis | CF | rhGH | recombinant human growth hormone | human growth hormone | HGH
Your slide tray is being processed.